Amar, SuneethaMuzaffar, MahvishNaqash, Abdul RafehVithayathil, Mathewet al2023-02-202023-02-2020221478-3223http://hdl.handle.net/10342/12345en-USanti-programmed death-ligandanti-vascular endothelial growth factorimmunotherapyImpact of Older Age in Patients Receiving Atezolizumab and Bevacizumab for Hepatocellular CarcinomaArticle10.1111/liv.15405